Finnish Foundation for Share Promotion and Nasdaq Helsinki has chosen Nanoform as the company of the month (article in Finnish)
Helsinki, Finland – Finnish Foundation for Share Promotion (Pörssisäätiö/Börsstiftelsen) and…
Nanoform sets a new near-term business target for 2021
Insider information Nanoform Finland Plc January 4th, 2021 at 08.10…
Nanoform included in Nasdaq First North 25 index as of Jan 4th, 2021
Helsinki, Finland – Nasdaq announced today the results of the…
Nanoform welcomed as a new member of Pharma Industry Finland (PIF)
Nanoform has been accepted as a new member of Pharma…
Video: The first ever human trial of a nanoformed drug
In partnership with Quotient Sciences, the healthy volunteers have been…
First dosing of nanoformed drug successfully accomplished
Press Release Nanoform Finland Plc December 21st, 2020 at 09.00…
Nanoform and Herantis partner to look for opportunities to enhance BBB penetration of CDNF and xCDNF molecules
Inside information Nanoform Finland Plc December 17, 2020 at 7:15 p.m.…